Milican inj. to be listed as medical insurance drug in July

Published: 2002-05-17 06:56:00

Updated: 2002-05-17 06:56:00

The Ministry of Health and Welfare (MOHW) has announced that Milican inj. of Dongwha Pharm, a new radioactive drug indicated in the treatment of liver cancer, will be listed as medical insurance drug at the ceiling price of 2,409,683 won per injectable set in July 1 following the final license on...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK